Dermata TherapeuticsDRMA
13F holders, Q4 2025 (December 31)7holders +2
3new positions
1sold out
$2.32avg. 13F price*
At the end of Q4 2025, 7 institutions reported holding Dermata Therapeutics Inc. (DRMA) in their 13F filings, up 2 from Q3 2025. 3 opened new positions and 1 sold out. The largest holders were Clear Street Group Inc. ($39K), Bank of America Corp. ($8K) and Barclays PLC ($6K).
- Company
- Dermata Therapeutics Inc.
- CUSIP
- 249845504
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $47K |
| Exits | 1 | $410K |
All 13F filers, Q3 2025 → Q4 2025: 25,124 shares bought and 90,464 shares sold, net −65,340 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Clear Street Group Inc. | 0.00% | New | 17,000 | $39K |
| Bank of America Corp. | 0.00% | Add +86325.0% | 3,457 | $8K |
| Barclays PLC | 0.00% | New | 2,402 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +369.3% | 1,999 | $5K |
| UBS Group AG | 0.00% | Reduce -87.7% | 1,237 | $3K |
| JPMorgan Chase & Co. | 0.00% | New | 696 | $2K |
| SBI Securities Co., Ltd. | 0.00% | No change | 101 | $234 |
"% of holder's portfolio" is DRMA's weight in each manager's 13F, not the share of Dermata Therapeutics Inc. the manager owns.